Financial Data and Key Metrics Changes - In 2025, the company achieved approximately 2% volume-led organic growth, with a strong performance in the fourth quarter, delivering 3% volume plus mix growth despite a slowdown in global weighted average category growth to roughly 60 basis points [38][39] - Adjusted free cash flow for the year was $1.9 billion, consistent with previous estimates, indicating the company's ability to maintain performance across quarters [39][45] - The company reported industry-leading gross productivity at 6.2% of Adjusted COGS, peaking at 7.2% in the fourth quarter, exceeding expectations [15] Business Line Data and Key Metrics Changes - The personal care business led the way in productivity improvements, with significant progress in categories like baby and childcare, which are highly competitive [16] - The company pivoted its portfolio towards higher growth, higher margin personal care categories, including the sale of its Brazilian tissue operations and PPE business, and exiting approximately $650 million of private label business [4][5] - Innovations in the personal care segment, such as Huggies' new products, contributed to strong volume growth and market share gains in various regions [24][28] Market Data and Key Metrics Changes - In international personal care markets, the company gained over 900 basis points of share in diapers over the past five years, while local competitors shifted focus away from China [20] - The company saw broad-based share gains in international personal care focus markets, with all focus markets delivering volume-led organic growth in Q4 [21][22] - In North America, the company achieved a third consecutive year of positive volume mix-led growth, with personal care growing value share by 20 basis points [27][28] Company Strategy and Development Direction - The company is focused on its "Powering Care" strategy, which emphasizes innovation, cost discipline, and a pivot towards higher margin categories [3][4] - The acquisition of Kenvue is seen as a significant step in the company's transformation, expected to enhance growth and create a scaled health and wellness leader [5][6] - The company aims to build a consumer-centric care model with a portfolio of ten iconic billion-dollar brands across critical life stages [5] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging environment, citing strong execution and a focus on innovation-led growth [19][39] - The outlook for 2026 includes expectations for mid- to high-single-digit constant currency adjusted EPS growth, driven by the Kenvue acquisition and ongoing operational improvements [47][48] - The company anticipates continued pressure on consumers and a focus on value, but remains committed to supporting its brands and driving growth initiatives [11][47] Other Important Information - The company has made significant investments in its North American manufacturing footprint, including a $2 billion investment to build an advanced manufacturing facility and an automated distribution center [16] - The company has improved its cash conversion cycle from 6 days in 2021 to around negative 10 days at the close of 2025, reflecting better working capital discipline [43] - The company has achieved a strong overhead leverage, expanding adjusted operating profit margins by 100 basis points over the past two years [42] Q&A Session Summary Question: What are the expectations for the Kenvue acquisition? - Management expects the Kenvue acquisition to be quickly accretive to earnings and value-enhancing for shareholders, with a focus on achieving significant synergies [37][53] Question: How is the company addressing competitive pressures? - The company is maintaining a disciplined approach to innovation and marketing, focusing on delivering superior consumer value propositions to navigate competitive pressures [19][27] Question: What is the outlook for 2026? - The company projects mid- to high-single-digit constant currency adjusted EPS growth for 2026, supported by the Kenvue acquisition and ongoing operational improvements [47][48]

POWERING CARE Forward-Looking Statements Certain matters contained in this presentation concerning our plans and expectations regarding the pending mergers with Kenvue and the pending International Family Care and Professional ("IFP") joint venture transaction with Suzano ("IFP Transaction"), the business outlook, including raw material, energy and other input costs, the anticipated charges and savings from the 2024 Transformation Initiative, cash flow and uses of cash, growth initiatives, innovations, mark ...

Core Insights - Kimberly-Clark Corporation reported fourth quarter and full year 2025 results, showcasing momentum from its innovation-driven growth strategy and significant efficiencies that support brand reinvestment and shareholder returns [1][2]. Financial Performance - Fourth quarter net sales were $4.1 billion, down 0.6%, with organic sales growth of 2.1% offset by a 2.5% decline due to exiting the private label diaper business in the US [4][11]. - Gross margin improved to 35.9% from 35.2% year-over-year, with an adjusted gross margin of 37.0%, consistent with the prior year [5][12]. - Operating profit for the quarter was $507 million, up from $420 million, with adjusted operating profit increasing 13.1% to $629 million [6][10]. - Diluted earnings per share (EPS) attributable to Kimberly-Clark were $1.50, a 11.9% increase from the prior year, while adjusted EPS rose 24.0% to $1.86 [10][18]. Yearly Overview - For the full year 2025, net sales totaled $16.4 billion, a decrease of 2.1%, primarily due to divestitures and currency translation impacts [11][12]. - The full year gross margin was 36.0%, down from 37.4% in the previous year, with an adjusted gross margin of 37.3% [12][13]. - Operating profit for the year was $2.4 billion, consistent with the prior year, while adjusted operating profit remained at $2.7 billion [13][24]. - Diluted EPS for the year was $6.07, down from $7.55, but adjusted EPS increased 3.2% to $7.53 [18][39]. Business Segment Results - North America segment net sales decreased 3.0% in Q4, driven by the exit of the private label diaper business, while organic sales growth was 0.8% [21][22]. - International Personal Care segment net sales increased 4.2% in Q4, with organic sales growth of 4.5% [25][26]. - For the full year, North America segment net sales were down 2.4%, while International Personal Care segment net sales decreased 0.9% [22][26]. Cash Flow and Shareholder Returns - Cash provided by operations was $2.8 billion, down from $3.2 billion, with capital spending increasing to $1.1 billion [29]. - The company returned $1.8 billion to shareholders through dividends and share repurchases, completing share repurchases of 1.1 million shares at a cost of $141 million [29]. 2026 Outlook - The company expects organic sales growth in 2026 to align with or exceed the average growth in its competitive categories, forecasting a mid-to-high single-digit growth rate for adjusted operating profit [30]. - Adjusted EPS from continuing operations is anticipated to grow double digits on a constant-currency basis, driven by a projected 30% increase in income from equity companies [30].

Group 1 - Goldman Sachs has promoted Ben Frost to chairman of investment banking, as per an internal memo [1] - Ben Frost led Goldman Sachs in completing two major transactions in the consumer retail sector last year, including advising Kenvue on its nearly $50 billion acquisition by Kimberly-Clark [1] - He also served as a financial advisor for Sycamore Partners in their approximately $24 billion acquisition of Walgreens Boots Alliance [1]

Group 1 - Barclays has cut its price target for Kimberly-Clark Corporation (KMB) from $132 to $102 while maintaining an Equal Weight rating, indicating a cautious outlook for the stock [2] - The recent enthusiasm for Kimberly-Clark shares is attributed to a "flight to safety" rather than improvements in the company's fundamentals, with concerns about company-specific and sector conditions persisting [3] - Institutional Shareholder Services (ISS) has recommended that Kimberly-Clark shareholders support the proposed acquisition of Kenvue, suggesting it could enhance the company's financial profile and key metrics [4][5] Group 2 - The proposed acquisition of Kenvue, valued at over $40 billion, aims to create a global consumer health platform that combines well-known brands from both companies [6] - ISS acknowledges potential shareholder concerns regarding the market's negative reaction to the acquisition announcement and uncertainties related to litigation involving Kenvue products, but believes the merger could unlock significant synergies [7] - Kimberly-Clark is recognized as a global consumer products company focused on improving care and hygiene through a range of essential products [8]

Core Viewpoint - Kimberly-Clark Corporation is actively pursuing a nearly $49 billion acquisition of Kenvue, which is seen as a bold move given Kenvue's stock has significantly decreased since its public offering [2] Group 1: Company Overview - Kimberly-Clark Corporation manufactures personal care products, including diapers, wipes, feminine and incontinence care products, and household paper goods [2] - The company's notable brands include Huggies, Kotex, Depend, Kleenex, Scott, and Cottonelle [2] Group 2: Acquisition Details - The planned acquisition of Kenvue includes its well-known over-the-counter products such as Tylenol, Band-Aids, and Aveeno [2] - Concerns have been raised regarding the potential risks associated with Kenvue, particularly related to Tylenol and its alleged links to autism, as mentioned by the Secretary of Health and Human Services [2] Group 3: Market Perspective - Jim Cramer highlighted that the weakness in Kimberly-Clark's stock may be more related to Kenvue's issues rather than Kimberly-Clark itself [1] - The company currently offers a 5% yield and is trading at 13 times earnings, which Cramer finds intriguing [1]

Core Viewpoint - Kimberly-Clark Corporation is facing challenges in its core categories, particularly in the diaper business due to declining birth rates, and is seeking growth through the planned acquisition of Kenvue for $48.7 billion, which could reshape its business mix and improve its income profile [3][4]. Group 1: Stock Performance and Analyst Ratings - Wells Fargo has lowered its price target for Kimberly-Clark to $105 from $110 while maintaining an Equal Weight rating, reflecting updates to its models across various sectors [2]. - The stock experienced a significant drop of over 22% in 2025, attributed to real challenges in its core categories [3]. Group 2: Strategic Initiatives - Management has been actively searching for growth levers, with the acquisition of Kenvue seen as a potential turning point that could restore growth and enhance the company's income profile, benefiting dividend investors [4]. - The acquisition is characterized as a major deal that could meaningfully reshape Kimberly-Clark's business mix [4]. Group 3: Market Position and Comparisons - Kimberly-Clark operates globally, focusing on products designed to deliver better care, but lacks the diversification seen in competitors like Procter & Gamble, which has a broader range of everyday staples [3].

Core Insights - Dividend Kings are companies that have consistently increased their dividends for at least 50 years, showcasing strong financial profiles and growth prospects [1] Company Summaries Coca-Cola - Coca-Cola has raised its dividend for 63 consecutive years, with a recent increase of 5.2% in early 2025, yielding 2.9%, which is more than double the S&P 500 average [4][6] - The company targets organic revenue growth of 4%-6% annually and aims for mid-to-high single-digit earnings-per-share growth, supported by significant capital investments [5] - Coca-Cola's strong balance sheet allows for strategic acquisitions, contributing to earnings growth from brands like Fairlife and BodyArmor [6] Kimberly Clark - Kimberly Clark has paid dividends for 91 years, increasing its payout for 53 consecutive years, with a recent 3.3% increase in January 2025, yielding 5% [7][8] - The company plans to invest over $2 billion in expanding U.S. manufacturing capacity to drive growth and innovation [8] - Kimberly Clark's acquisition of Kenvue for $48.7 billion is expected to add significant brands and deliver $2.1 billion in annual synergies, supporting continued dividend growth [9] Johnson & Johnson - Johnson & Johnson has a dividend growth streak of 63 years, with a 4.8% increase in 2025 [8]

Group 1: Investment Outlook - Kimberly-Clark Corporation (KMB) is recognized as one of the 14 Best Dividend Aristocrats to invest in heading into 2026 [1] - Citi has lowered its price target for KMB from $100 to $95, maintaining a Sell rating, as part of a broader shift in outlook for the household care sector [2] Group 2: Strategic Developments - Kimberly-Clark is in the process of acquiring Kenvue, which is expected to generate $2.1 billion in cost synergies and be accretive for shareholders over time [3] - The company is expanding its manufacturing footprint in Vietnam, having purchased 1.2 hectares of land to increase production by approximately 40%, supporting a broader export strategy [4] Group 3: Digital Engagement - Kimberly-Clark is exploring new strategies to enhance its competitiveness in a digital environment, focusing on deeper engagement with parenting communities and a push into e-commerce [5]

Core Insights - Target is facing pressure from an activist investor, Toms Capital Investment Management (TCIM), amid declining sales and a nearly one-third drop in stock price this year [2][6] - TCIM has established a significant stake in Target, although the exact size of the holding is unclear [2][6] - Target's stock has fallen over 60% from its pandemic-era peak, with the company reporting its 12th consecutive quarter of negative or nearly zero sales growth [2][6] Company Performance - Target's stock price rose by 3.7% recently, bringing the company's market capitalization to $44.3 billion [3][6] - The company has acknowledged ongoing communication with all shareholders and emphasized its commitment to returning to a growth trajectory [4][7] Strategic Focus - Target's current strategy focuses on three main areas: achieving product leadership, providing a consistent high-quality shopping experience, and leveraging technological advantages [4][7] - The company expresses confidence that executing this strategy will drive business forward and create sustainable long-term value for shareholders [4][7]